Biosynex Acquires ProciseDx
Biosynex SA announced on June 13 that it entered an agreement to acquire ProciseDx for an undisclosed price. According to data captured in the LevinPro HC database, this transaction represents the 68th Laboratories, MRI and Dialysis acquisition of 2023, and the 33rd in the diagnostic subsector. ProciseDx is an in vitro diagnostics company with a proprietary instrument platform and portfolio of point-of-care diagnostic tests. It is based in San Diego, California. Biosynex is a French market leader specializing in the design and distribution of rapid tests. Biosynex designs, manufactures and distributes Rapid Diagnostic Tests, as well as diagnostic equipment for healthcare... Read More »
Avacta Group Acquires Coris BioConcept for $9.2 Million
Avacta Group plc has acquired Coris BioConcept for £7.4 million, approximately $9.2 million USD, with an earnout based on future business performance, payable in cash, of up to £3 million. According to data captured in the LevinPro HC database, this marks the 63rd Laboratories, MRI and Dialysis transaction of the year and the 31st in the diagnostic subsector. Coris BioConcept is a middle-sized company specialized in developing, manufacturing and marketing rapid diagnostic test kits, mainly lateral flow tests, for use by healthcare professionals. Coris BioConcept was established in 1996 and is based in Gembloux, Belgium. Avacta Group plc is a life sciences company. The company is focused on... Read More »
healthŌme Acquires Kailos Genetics
healthŌme™ Inc. announced earlier this week its acquisition of Kailos Genetics, LLC for an undisclosed price. Kailos Genetics is a CLIA-certified and CAP-accredited genetic testing laboratory and supplier of clinical grade laboratory reagents for next-generation sequencing. healthŌme is a leading genomics-based, health navigation company based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. healthŌme, in partnership with Hannover Re US, the reinsurer for healthŌme’s new first-of-its-kind, patent pending cancer program, designs, develops and delivers its health management solutions through a network of life and critical insurance carriers. With the acquisition, Kailos... Read More »
MedGenome Acquires Prognosis Laboratories
MedGenome Labs Ltd. announced on May 29 that it acquired Prognosis Laboratories for an undisclosed price. Wodehouse Capital was the exclusive financial advisor to Prognosis Laboratories. Wodehouse Capital was assisted by Khaitan & Co. as legal advisors to the undisclosed sellers. Prognosis Laboratories is a private diagnostic center in India that has been granted permission to conduct COVID-19 tests. It also provides cardiology, radio diagnosis, pathology, infertility, ultrasonography, ECG, hematology and digital X-ray services. It was founded in 2013 and is based in Dwarka, New Delhi. MedGenome Labs is a leading genetic diagnostics and research and data company based in India,... Read More »
MedVenture Health Acquires Canyon Labs
On May 16, MedVenture Health, a venture capital and private equity firm, announced it acquired Canyon Labs for an undisclosed price. According to the LevinPro HC database, this acquisition represents the 55th Laboratories, MRI and Dialysis transaction of the year. Canyon Labs provides laboratory testing, consulting, clinical research and Institutional Review Board services for pharmaceutical, nutraceutical and medical devices. It is based in Bluffdale, Utah. MedVenture partners with entrepreneurs, physicians and management teams to advance healthcare products, services and technologies. It is based in Salt Lake City, Utah and was founded in 2016. This marks MedVenture’s first... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
